REFERENCES
- Conroy T,Desseigne F, Ychou M, Bouché O, Guimbaud R, Bécouarn Y, FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011;364(19):1817–1825.
- Siegel R,Ma J, Zou Z, Jemal A.Cancer statistics, 2014. CA Cancer J Clin 2014;64(1):9–29.
- Bilimoria KY,Bentrem DJ, Ko CY, Ritchey J, Stewart AK, Winchester DP, et al.Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database. Cancer 2007;110(4):738–744.
- Kayahara M,Nagakawa T, Ueno K, Ohta T, Takeda T, Miyazaki I.An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging. Cancer 1993;72(7):2118–2123.
- Katz MH,Wang H, Fleming JB, Sun CC, Hwang RF, Wolff RA, Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol 2009;16(4):836–847.
- Riall TS,Cameron JL, Lillemoe KD, Winter JM, Campbell KA, Hruban RH, Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up. Surgery 2006;140(5):764–772.
- Seufferlein T,Bachet JB, Van Cutsem E, Rougier P.Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012;23(Suppl 7):33–40.
- Barugola G,Falconi M, Bettini R, Boninsegna L, Casarotto A, Salvia R, The determinant factors of recurrence following resection for ductal pancreatic cancer. JOP 2007;8(1 Suppl):132–140.
- Arnaoutakis GJ,Rangachari D, Laheru DA, Iacobuzio-Donahue CA, Hruban RH, Herman JM, Pulmonary resection for isolated pancreatic adenocarcinoma metastasis: an analysis of outcomes and survival. J Gastrointest Surg 2011;15(9):1611–1617.
- Kitasato Y,Nakayama M, Akasu G, Yoshitomi M, Mikagi K, Maruyama Y, Metastatic pulmonary adenocarcinoma 13 years after curative resection for pancreatic cancer: report of a case and review of Japanese literature. JOP 2012;13(3):296–300.
- Ramaekers F,Van Niekerk C, Poels L, Schaafsma E, Huijsmans A, Robben H, Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas. Am J Pathol 1990;136(3):641–655.
- Matoso A,Singh K, Jacob R, Greaves WO, Tavares R, Noble L, Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in pulmonary and nonpulmonary primary tumors. Appl Immunohistochem Mol Morphol 2010;18(2):142–149.
- Park SY,Kim BH, Kim JH, Lee S, Kang GH.Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma. Arch Pathol Lab Med 2007;131(10):1561–1567.
- Iida T,Nakabayashi Y, Okui N, Shiba H, Otsuka M, Yanaga K.Successful management of metachronous liver metastasis after pancreaticoduodectomy for pancreatic ductal carcinoma using hepatectomy and chemotherapy: a case report. Anticancer Res 2014;34(5):2417–2420.
- Snider, JW,Oermann EK, Chen V, Rabin J, Suy S, Yu X.CyberKnife with tumor tracking: an effective treatment for high-risk surgical patients with single peripheral lung metastases. Front Oncol 2012;2:63.